Review pending. Every figure has been located on its cited source page in an AI-assisted source verification (matched to the document's text) (17 October 2026). Independent review has not yet been carried out, and these pages are not indexed.AI-assisted source check done; independent review pending; not indexed. About the review
UBP
On this page
Company details
- Legal name
- The United Basalt Products Limited
- Listing
- No ticker printed on the Stock Exchange of Mauritius, active (observed 2026-10-08)
- Sector
- Not classified (our classification from the stated principal activity)
- Financial year ends
- 30 June
Overview
Year ended 30 June 2025 · annual report, signed / final · source
-
Revenue
MUR 8.40 billion
8,399,921 MUR thousands · p67
+64.1% vs 2024
-
Operating profit / (loss)
MUR 694 million
694,347 MUR thousands · p67
+109.9% vs 2024
-
Profit / (loss) for the year
MUR 239 million
238,761 MUR thousands · p67
+14.5% vs 2024
-
Total assets
MUR 13.6 billion
13,641,444 MUR thousands · p67
+44.2% vs 2024
-
Total equity
MUR 4.21 billion
4,209,447 MUR thousands · p67
−4.3% vs 2024
-
Cash from operations
MUR 1.00 billion
1,001,630 MUR thousands · p69
+85.5% vs 2024
Large amounts are rounded for reading (MUR million / billion / trillion); exact figures as printed are under each amount and in the tables. No currency conversion.
Financial statements
Exact figures as printed. Each column comes from one filing; labels are as printed in the newest filing. Amounts in MUR thousands unless the row says otherwise; brackets are negative.
† from a supplementary filing for the same year · ‡ signed audited statements preferred over a disputed figure · “–” is a printed dash, explained below the table
Column sources
- FY to 30 Jun 2025 — annual report, signed / final; reported for the year · source
- FY to 30 Jun 2024 — annual report, signed / final; comparative in the FY to 30 Jun 2025 filing · source
Income statement
| Line (as printed) | FY to 30 Jun 2025Annual reportreported for the year | FY to 30 Jun 2024Annual reportcomparative in FY to 30 Jun 2025 filing |
|---|---|---|
| Revenue | 8,399,921 | 5,118,175 |
| Operating profit | 694,347 | 330,769 |
| Allowance for expected credit losses on financial assets | (53,229) | 369 |
| Impairment of subsidiaries1 | –2 | –2 |
| Finance income | 8,225 | 465 |
| Finance costs | (361,044) | (151,047) |
| Share of results of associates | 12,826 | 16,467 |
| Profit before tax | 301,125 | 197,023 |
| Tax expense | (62,364) | (23,665) |
| Profit for the year from continuing operations3 | 238,761 | 173,358 |
| Profit for the year from discontinued operation4 | –5 | 35,231 |
| Profit for the year | 238,761 | 208,589 |
| Exchange differences on translation of foreign operations6 | 7,468 | (9,165) |
| Reclassification adjustment relating to foreign operations disposed of in the year7 | –8 | (28,535) |
| Net other comprehensive income / (loss) to be reclassified to profit or loss in subsequent years9 | 7,468 | (37,700) |
| Re-measurement gains / (losses) on employee benefit liabilities10 | 21,635 | (37,449) |
| Deferred tax effect on re-measurement (gains) / losses on employee benefit liabilities11 | (4,164) | 6,075 |
| Share of other comprehensive loss of associates12 | (941) | (1,893) |
| Net other comprehensive income / ( loss) not to be reclassified to profit or loss in subsequent years13 | 16,530 | (33,267) |
| Other comprehensive income / (loss) for the year, net of tax | 23,998 | (70,967) |
| Total comprehensive income for the year, net of tax | 262,759 | 137,622 |
| Non-controlling interests14 | 22,700 | 11,308 |
- Printed “–”, read as nil: subtotal_arithmetic: is.profit_before_tax.
- Printed “–”, read as nil: subtotal_arithmetic: is.profit_for_year.
- Printed “–”, read as nil: subtotal_arithmetic: is.native.co_hp3dxscxw1e7.oci_to_be_reclassified.
Notes and alternative reported figures (11)
- “Impairment of subsidiaries” is an issuer-specific line, not mapped to a shared definition: Note 27(c); nil in the Group columns.
- “Profit for the year from continuing operations” is an issuer-specific line, not mapped to a shared definition: Continuing operations.
- “Profit for the year from discontinued operation” is an issuer-specific line, not mapped to a shared definition: Note 40; discontinued operation.
- “Exchange differences on translation of foreign operations” is an issuer-specific line, not mapped to a shared definition: OCI item to be reclassified.
- “Reclassification adjustment relating to foreign operations disposed of in the year” is an issuer-specific line, not mapped to a shared definition: Note 40; OCI item to be reclassified.
- “Net other comprehensive income / (loss) to be reclassified to profit or loss in subsequent years” is an issuer-specific line, not mapped to a shared definition: OCI subtotal.
- “Re-measurement gains / (losses) on employee benefit liabilities” is an issuer-specific line, not mapped to a shared definition: Note 21; OCI item.
- “Deferred tax effect on re-measurement (gains) / losses on employee benefit liabilities” is an issuer-specific line, not mapped to a shared definition: Note 13(a); OCI item.
- “Share of other comprehensive loss of associates” is an issuer-specific line, not mapped to a shared definition: Note 11; OCI item.
- “Net other comprehensive income / ( loss) not to be reclassified to profit or loss in subsequent years” is an issuer-specific line, not mapped to a shared definition: OCI subtotal.
- “Non-controlling interests” is an issuer-specific line, not mapped to a shared definition: Printed 'Non-controlling interests' under 'Profit for the year attributable to:'.
Balance sheet
| Line (as printed) | FY to 30 Jun 2025Annual reportreported for the year | FY to 30 Jun 2024Annual reportcomparative in FY to 30 Jun 2025 filing |
|---|---|---|
| Property, plant and equipment | 6,921,995 | 4,895,973 |
| Mineral assets1 | 936,967 | –2 |
| Right of use assets | 545,125 | 362,015 |
| Investment properties | 61,878 | 48,055 |
| Bearer biological assets3 | 4,921 | 4,260 |
| Intangible assets | 949,806 | 250,289 |
| Land conversion rights4 | 27,774 | 27,198 |
| Investment in subsidiaries5 | –2 | –2 |
| Advance towards equity6 | –2 | –2 |
| Investment in associates | 35,790 | 42,726 |
| Non-current financial assets7 | 28,688 | 2,351 |
| Deferred tax assets | 32,122 | 20,302 |
| Total non-current assets | 9,545,066 | 5,653,169 |
| Consumable biological assets8 | 184,123 | 130,682 |
| Inventories | 2,182,903 | 1,397,614 |
| Trade and other receivables | 1,215,568 | 620,226 |
| Income tax receivable | 18,534 | 16,308 |
| Restricted cash9 | –10 | 1,357,637 |
| Cash at bank and on hand | 495,250 | 281,545 |
| Total non-current assets | 4,096,378 | 3,804,012 |
| TOTAL ASSETS | 13,641,444 | 9,457,181 |
| Issued capital and share premium11 | 272,454 | 272,454 |
| Reserves12 | 3,729,073 | 4,025,561 |
| Equity | 4,001,527 | 4,298,015 |
| Non-controlling interests | 207,920 | 99,818 |
| Total equity | 4,209,447 | 4,397,833 |
| Loans | 3,057,221 | 2,970,372 |
| Lease liabilities | 420,505 | 281,085 |
| Deferred tax liabilities | 736,027 | 147,153 |
| Employee benefit liabilities | 284,001 | 301,493 |
| Derivative financial instrument | 4,114 | –13 |
| Gross obligations under options14 | 488,843 | –13 |
| Total non-current liabilities | 4,990,711 | 3,700,103 |
| Loans and bank overdrafts | 2,847,800 | 443,006 |
| Lease liabilities | 135,462 | 97,334 |
| Trade and other payables | 1,392,412 | 755,252 |
| Dividend payable | 52,033 | 55,249 |
| Income tax payable | 13,579 | 8,404 |
| Total current liabilities | 4,441,286 | 1,359,245 |
| Total liabilities | 9,431,997 | 5,059,348 |
| TOTAL EQUITY AND LIABILITIES | 13,641,444 | 9,457,181 |
- Printed “–”, read as nil: subtotal_arithmetic: bs.non_current_assets.
- Printed “–”, read as nil: subtotal_arithmetic: bs.current_assets.
- Printed “–”, read as nil: subtotal_arithmetic: bs.non_current_liabilities.
Notes and alternative reported figures (11)
- “Mineral assets” is an issuer-specific line, not mapped to a shared definition: Note 5(b) (non-current).
- “Bearer biological assets” is an issuer-specific line, not mapped to a shared definition: Note 8.
- “Land conversion rights” is an issuer-specific line, not mapped to a shared definition: Note 9(b).
- “Investment in subsidiaries” is an issuer-specific line, not mapped to a shared definition: Note 10(a); nil in the Group columns.
- “Advance towards equity” is an issuer-specific line, not mapped to a shared definition: Note 10(b); nil in the Group columns.
- “Non-current financial assets” is an issuer-specific line, not mapped to a shared definition: Note 12.
- “Consumable biological assets” is an issuer-specific line, not mapped to a shared definition: Note 14 (current).
- “Restricted cash” is an issuer-specific line, not mapped to a shared definition: Note 18 (current).
- “Issued capital and share premium” is an issuer-specific line, not mapped to a shared definition: Note 19(a); share capital and share premium printed as one line.
- “Reserves” is an issuer-specific line, not mapped to a shared definition: Note 19(b); all reserves attributable to owners, including retained earnings.
- “Gross obligations under options” is an issuer-specific line, not mapped to a shared definition: Note 23 (non-current).
Cash flow
| Line (as printed) | FY to 30 Jun 2025Annual reportreported for the year | FY to 30 Jun 2024Annual reportcomparative in FY to 30 Jun 2025 filing |
|---|---|---|
| Cash generated from operations | 1,407,821 | 704,098 |
| Interest paid | (360,895) | (151,240) |
| Interest income | 8,225 | 465 |
| Income tax paid | (53,521) | (13,243) |
| Net cash flows generated from operating activities | 1,001,630 | 540,080 |
| Proceeds from disposal of property, plant and equipment | 46,148 | 16,832 |
| Proceeds from disposal of investment properties1 | 68,000 | –2 |
| Purchase of property, plant and equipment | (442,716) | (401,751) |
| Expenditure on bearer assets3 | (405) | (3,135) |
| Additions to investment in subsidiaries4 | –2 | –2 |
| Purchase of investment properties5 | –2 | –2 |
| Purchase of intangible assets | (17,397) | (9,620) |
| Consideration paid to acquire additional shares in financial asset and subsidiary6 | (4,092,375) | –2 |
| Cash on disposal of subsidiary7 | –2 | 151 |
| Cash on acquisition of subsidiary8 | 269,583 | –2 |
| Dividend received from associates9 | 18,821 | 18,975 |
| Dividend received from other equity investment10 | –2 | –2 |
| Net cash flows (used in) / generated from investing activities | (4,150,341) | (378,548) |
| Proceeds from borrowings | 3,737,024 | 7,633,044 |
| Repayment of term loans | (1,514,556) | (5,296,798) |
| Repayment of lease liabilities | (140,223) | (94,390) |
| Long Term Secured Promissory Note11 | –12 | (670,490) |
| Transactions with non-controlling interest13 | 93,487 | 54,429 |
| Dividend paid | (46,393) | –12 |
| Dividend paid - Minority shareholders14 | (8,368) | (9,456) |
| Net cash flows generated from / (used in) financing activities | 2,120,971 | 1,616,339 |
| (Decrease) / Increase in cash and cash equivalents | (1,027,740) | 1,777,871 |
| At July 01, | 1,429,945 | (335,939) |
| Exchange difference | (43,088) | (11,987) |
| At June 30, | 359,117 | 1,429,945 |
- Printed “–”, read as nil: subtotal_arithmetic: cf.cash_from_investing.
- Printed “–”, read as nil: subtotal_arithmetic: cf.cash_from_financing.
Notes and alternative reported figures (12)
- “Proceeds from disposal of investment properties” is an issuer-specific line, not mapped to a shared definition: Investing.
- “Expenditure on bearer assets” is an issuer-specific line, not mapped to a shared definition: Note 8; investing.
- “Additions to investment in subsidiaries” is an issuer-specific line, not mapped to a shared definition: Note 10(a); investing; nil for the Group.
- “Purchase of investment properties” is an issuer-specific line, not mapped to a shared definition: Note 7; investing; nil for the Group.
- “Consideration paid to acquire additional shares in financial asset and subsidiary” is an issuer-specific line, not mapped to a shared definition: Note 39; investing.
- “Cash on disposal of subsidiary” is an issuer-specific line, not mapped to a shared definition: Note 40; investing.
- “Cash on acquisition of subsidiary” is an issuer-specific line, not mapped to a shared definition: Note 39; investing.
- “Dividend received from associates” is an issuer-specific line, not mapped to a shared definition: Note 11; investing.
- “Dividend received from other equity investment” is an issuer-specific line, not mapped to a shared definition: Note 28; investing.
- “Long Term Secured Promissory Note” is an issuer-specific line, not mapped to a shared definition: Note 20(c); financing (repayment in 2024).
- “Transactions with non-controlling interest” is an issuer-specific line, not mapped to a shared definition: Financing.
- “Dividend paid - Minority shareholders” is an issuer-specific line, not mapped to a shared definition: Financing; dividends paid to non-controlling interests.
Segments
Segment data not yet collected for this company in the pilot.
Dividends
Proposed or recommended, declared and paid are different events and are kept apart. A statement that no dividend was proposed does not mean none was paid.
| Year ended | Event | Wording as printed | Amount | Unit | Source |
|---|---|---|---|---|---|
| 30 Jun 2025 | Dividends paid (cash flow statement) | Dividend paid |
(46,393) | MUR thousands | Annual report, p69 |
| 30 Jun 2024 | Dividends paid (cash flow statement) | Dividend paid |
0printed “–”, read as nil | MUR thousands | Annual report, p69 |
Sources
Each filing used on this page, newest period first. Dates are the document's own; the date we retrieved a file is shown separately and is never a publication date.
-
The United Basalt Products Limited 2025 Integrated Report
Year ended 30 June 2025 · Annual report · signed / final
Audit: Deloitte (Chartered Accountants); engagement partner LLK Ah Hee, FCCA, unmodified opinion · signed
Final status: Independent auditor's report on the consolidated and separate financial statements (pages 130 to 215), unmodified, signed by hand by Deloitte, Chartered Accountants, and LLK Ah Hee FCCA, licensed by FRC, dated September 25, 2025 (PDF pp65-66). Statements approved by the Board on September 25, 2025 and hand-signed by Jean-Claude Béga (Chairperson) and Kalindee Ramdhonee (Director) (PDF p67).
- Document date
- 25 Sep 2025
- Auditor's report
- 25 Sep 2025
- Board approval
- 25 Sep 2025
- Retrieved by us
- 8 Oct 2026 (not a publication date)
- Used for
- statement columns FY to 30 Jun 2025, FY to 30 Jun 2024
- Basis
- consolidated statements · MUR thousands (printed “Rs'000”)
- The current-assets total (4,096,378; 2024: 3,804,012) is printed with the label 'Total non-current assets', the same label as the non-current total above it (PDF p67). Transcribed as current assets (occurrence 2); the figures equal the sum of the current-asset lines.
- Cash-flow cash and cash equivalents differ from balance-sheet 'Cash at bank and on hand' (cf.closing/opening_equals_balance_sheet checks fail): note 18 (PDF p95) reconciles them as cash at banks and on hand 495,250 (2024: 281,545) less bank overdraft (note 20) (136,133) (2024: (209,237)) = 359,117 (2024: 72,308), and 2024 cash-flow cash 1,429,945 also includes restricted cash 1,357,637 (note 10(a)). Overdrafts sit within current 'Loans and bank overdrafts' (p67).
- Revenue is followed directly by 'Operating profit' (note 27): no cost lines are printed on the face of the income statement (p67).
Technical details
- File
- 117 pages, with a text layer
- SHA-256
1a1005af682311af729a30acfe7ef583dfcb86641e78cd5408af20f666c13c76- Entity as printed
- The United Basalt Products Limited
- Issuer copy
- retrieved 2026-10-08T19:14:13Z
Data notes
No figure-level notes beyond those in the tables.
Review status: every figure has been located on its cited source page in an AI-assisted source verification (matched to the document's text) (17 October 2026). Independent review is pending for every figure; automated checks and the AI-assisted verification are not independent review.
Download
Figures shown on this page (CSV) — the same selected figures at their exact printed values, each with its source document, SHA-256, page, selection rule and reading. Independent review of these figures is pending.